🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareStarted this morning and already overthinking everything — my results so far Page 3

Started this morning and already overthinking everything — my results so far

hans_munich Wed, Sep 11, 2024 at 11:16 PM 56 replies 2,355 viewsPage 3 of 12
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Sep 12, 2024 at 8:24 AM#11
Dr.GutHealth said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

Last edited: Sep 12, 2024 at 2:24 PM
34 9CarlaRPh_TPA, steph_laguna, fiona_glasgow and 31 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Sep 12, 2024 at 12:12 PM#12
patPC_UT said:
PeptideChemSF said: ...regarding the trial evidence...

This answered a question I did not know how to ask. Printing the relevant bit and taking it with me.

33 8NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 30 others
Reply Quote Save Share Report
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Sep 12, 2024 at 4:00 PM#13
Dr.GutHealth said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

32 7BrianDallas92, labquiet_amy, emily_PDX and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Sep 12, 2024 at 7:48 PM#14

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

That is the short version; the long version is somebody else's post.

31 6FranDenver, Dr.BariatricHTX, LindaRN_retired and 28 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 12, 2024 at 11:36 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. No action needed from anybody.

Last edited: Sep 13, 2024 at 1:36 AM
30 5PurityPaulOR, MaxMetOK, MounjBrad and 27 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register